Maria E. Arcila

2009–2025 年に発表

187
論文数
47,062
被引用数
104
h 指数
182
i10 指数

被引用数

Maria E. Arcila の年別被引用数1976 年: 被引用 3 件1991 年: 被引用 1 件1992 年: 被引用 1 件1993 年: 被引用 1 件1997 年: 被引用 1 件1998 年: 被引用 3 件1999 年: 被引用 2 件2000 年: 被引用 2 件2004 年: 被引用 2 件2007 年: 被引用 2 件2008 年: 被引用 1 件2009 年: 被引用 2 件2010 年: 被引用 10 件2011 年: 被引用 58 件2012 年: 被引用 123 件2013 年: 被引用 284 件2014 年: 被引用 279 件2015 年: 被引用 416 件2016 年: 被引用 514 件2017 年: 被引用 596 件2018 年: 被引用 843 件2019 年: 被引用 2,455 件2020 年: 被引用 3,054 件2021 年: 被引用 2,975 件2022 年: 被引用 2,329 件2023 年: 被引用 1,770 件2024 年: 被引用 2,562 件2025 年: 被引用 1,261 件2026 年: 被引用 42 件1977〜1990 年は被引用が無いため表示していません1994〜1996 年は被引用が無いため表示していません2001〜2003 年は被引用が無いため表示していません2005〜2006 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 6,923 件、この内訳の 29.3%中国: 引用元論文 2,735 件、この内訳の 11.6%イタリア: 引用元論文 1,308 件、この内訳の 5.5%イギリス: 引用元論文 1,184 件、この内訳の 5%ドイツ: 引用元論文 1,133 件、この内訳の 4.8%フランス: 引用元論文 1,001 件、この内訳の 4.2%日本: 引用元論文 992 件、この内訳の 4.2%スペイン: 引用元論文 812 件、この内訳の 3.5%カナダ: 引用元論文 760 件、この内訳の 3.2%オランダ: 引用元論文 597 件、この内訳の 2.5%スイス: 引用元論文 549 件、この内訳の 2.3%韓国: 引用元論文 549 件、この内訳の 2.3%
0%29.3%その他 21.6%

分野

  • Medicine70.5%
  • Biochemistry, Genetics and Molecular Biology24.3%
  • Immunology and Microbiology2.7%
  • Computer Science0.8%
  • Engineering0.4%
  • Chemistry0.3%
  • その他1%

トピック

  • Lung Cancer Treatments and Mutations10.1%
  • Cancer Genomics and Diagnostics7.6%
  • Cancer Immunotherapy and Biomarkers4.2%
  • Lung Cancer Research Studies3.6%
  • CAR-T cell therapy research3.5%
  • Lung Cancer Diagnosis and Treatment2.3%
  • その他68.7%

共著者

全論文

検索で開く
  1. Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Laetitia Borsu, Justyna Sadowska, Jacklyn Casanova, Ruben Bacares, Iwona Kiecka, Anna Razumova, Julie B Son, Lisa Stewart, Tessara Baldi, Kerry Mullaney, Hikmat Al‐Ahmadie, Efsevia Vakiani, Adam Abeshouse, Alexander Penson, Philip Jonsson, Niedzica Camacho, Matthew T. Chang, Helen Won, Benjamin Groß, Ritika Kundra, Zachary Heins, Hsiao‐Wei Chen, Sarah Phillips, Hongxin Zhang, Jiaojiao Wang, Angelica Ochoa, Jonathan Wills, Michael Eubank, Stacy B. Thomas, Stuart M. Gardos, Dalicia N. Reales, Jesse Galle, Robert Durany, Roy Cambria, Wassim Abida, Andrea Cercek, Darren R. Feldman, Mrinal M. Gounder, A. Ari Hakimi, James J. Harding, Gopa Iyer, Yelena Y. Janjigian, Emmet Jordan, Ciara M. Kelly, Maeve A. Lowery, Luc G.T. Morris, Antonio Omuro, Nitya Raj, Pedram Razavi, Alexander N. Shoushtari, Neerav Shukla, Tara E. Soumerai, Anna M. Varghese, Rona Yaeger, Jonathan Coleman, Bernard H. Bochner, Gregory J. Riely, Leonard B. Saltz, Howard I. Scher, Paul Sabbatini, Mark E. Robson, David S. Klimstra, Barry S. Taylor, José Baselga, Nikolaus Schultz, David M. Hyman, Maria E. Arcila, David B. Solit, Marc Ladanyi, Michael F. Berger - Nature Medicine 2017 被引用: 3,517

  2. Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT)

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Molecular Diagnostics 2015 被引用: 2,155

  3. Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michel Sadelain, Renier J. Brentjens - Science Translational Medicine 2014 被引用: 2,497

  4. Cancer therapy shapes the fitness landscape of clonal hematopoiesis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Konrad H. Stopsack, Barbara Spitzer, Simon Mantha, James A. Fagin, Laura Boucai, Christopher J. Gibson, Benjamin L. Ebert, Andrew L. Young, Todd E. Druley, Koichi Takahashi, Nancy Gillis, Markus Ball, Eric Padron, David M. Hyman, José Baselga, Larry Norton, Stuart M. Gardos, Virginia M. Klimek, Howard I. Scher, Dean F. Bajorin, Eder Paraiso, Ryma Benayed, Maria E. Arcila, Marc Ladanyi, David B. Solit, Michael F. Berger, Martin S. Tallman, Montserrat García‐Closas, Nilanjan Chatterjee, Luis A. Díaz, Ross L. Levine, Lindsay M. Morton, Ahmet Zehir, Elli Papaemmanuil - Nature Genetics 2020 被引用: 741

  5. Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical Outcomes

    著者: , , , , , , , , , , , , , , - Cell stem cell 2017 被引用: 855

  6. Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Thoracic Oncology 2021 被引用: 645

  7. Molecular Determinants of Response to Anti–Programmed Cell Death (PD)-1 and Anti–Programmed Death-Ligand 1 (PD-L1) Blockade in Patients With Non–Small-Cell Lung Cancer Profiled With Targeted Next-Generation Sequencing

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nikolaus Schultz, Matthew D. Hellmann - Journal of Clinical Oncology 2018 被引用: 1,421

  8. Analysis of Tumor Specimens at the Time of Acquired Resistance to EGFR-TKI Therapy in 155 Patients with EGFR -Mutant Lung Cancers

    著者: , , , , , , , , , - Clinical Cancer Research 2013 被引用: 2,475

  9. Quantifying the Expanding Landscape of Clinical Actionability for Patients with Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2023 被引用: 391

  10. Tumor Analyses Reveal Squamous Transformation and Off-Target Alterations As Early Resistance Mechanisms to First-line Osimertinib in EGFR -Mutant Lung Cancer

    著者: , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2020 被引用: 383

  11. HER2-Mediated Internalization of Cytotoxic Agents in ERBB2 Amplified or Mutant Lung Cancers

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Anuja Bhalkikar, Fabiola Cecchi, David M. Hyman, Jason S. Lewis, Darren J. Buonocore, Alan L. Ho, Vicky Makker, Jorge S. Reis‐Filho, Pedram Razavi, Maria E. Arcila, Mark G. Kris, John T. Poirier, Ronglai Shen, Junji Tsurutani, Gary A. Ulaner, Elisa de Stanchina, Neal Rosen, Charles M. Rudin, Maurizio Scaltriti - Cancer Discovery 2020 被引用: 289

  12. Guidelines for Validation of Next-Generation Sequencing–Based Oncology Panels

    著者: , , , , , , , , - Journal of Molecular Diagnostics 2017 被引用: 730

  13. Ado-Trastuzumab Emtansine for Patients With HER2-Mutant Lung Cancers: Results From a Phase II Basket Trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2018 被引用: 559

  14. Lactose drives Enterococcus expansion to promote graft-versus-host disease

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Anthony D. Sung, Daigo Hashimoto, Christof Scheid, João B. Xavier, Julia A. Messina, Kristi Romero, M. Lew, Amy Bush, Lauren Bohannon, Kasumi Hayasaka, Yuta Hasegawa, Maria J. G. T. Vehreschild, Justin R. Cross, Doris M. Ponce, Miguel‐Angel Perales, Sergio Giralt, Robert R. Jenq, Takanori Teshima, Ernst Holler, Nelson J. Chao, Eric G. Pamer, Jonathan U. Peled, Marcel R.M. van den Brink - Science 2019 被引用: 369

  15. Concurrent RB1 and TP53 Alterations Define a Subset of EGFR-Mutant Lung Cancers at risk for Histologic Transformation and Inferior Clinical Outcomes

    著者: , , , , , , , , , , , , , , , , - Journal of Thoracic Oncology 2019 被引用: 448

  16. Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology

    著者: , , , , , , , , , , , , , , , , , , , , , - Archives of Pathology & Laboratory Medicine 2018 被引用: 931

  17. Prospective Genomic Profiling of Prostate Cancer Across Disease States Reveals Germline and Somatic Alterations That May Affect Clinical Decision Making

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Barry S. Taylor, Marc Ladanyi, Diana Mandelker, Liying Zhang, Victor E. Reuter, Philip W. Kantoff, David B. Solit, Michael F. Berger, Charles L. Sawyers, Nikolaus Schultz, Howard I. Scher - JCO Precision Oncology 2017 被引用: 531

  18. Effects of Co-occurring Genomic Alterations on Outcomes in Patients with KRAS -Mutant Non–Small Cell Lung Cancer

    著者: , , , , , , , , , , , , , , , - Clinical Cancer Research 2017 被引用: 460

  19. Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kenneth Ng, Juliana Eng, Isabel R. Preeshagul, W. Victoria Lai, John J. Fiore, Afsheen N. Iqbal, Daniela Molena, Gaetano Rocco, Bernard J. Park, Lee P. Lim, Mark Junjie Li, Candace Tong-Li, Madhawa De Silva, David Chan, Connie I. Diakos, Malinda Itchins, Stephen Clarke, Nick Pavlakis, Adrian V. Lee, Natasha Rekhtman, Jason C. Chang, William D. Travis, Gregory J. Riely, David B. Solit, Mithat Gönen, Valerie W. Rusch, Andreas Rimner, Daniel R. Gomez, Alexander Drilon, Howard I. Scher, Sohrab P. Shah, Michael F. Berger, Maria E. Arcila, Marc Ladanyi, Ross L. Levine, Ronglai Shen, Pedram Razavi, Jorge S. Reis‐Filho, David R. Jones, Charles M. Rudin, James M. Isbell, Bob T. Li - Nature Medicine 2022 被引用: 185

  20. Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Genetics 2012 被引用: 1,220

  21. MET-dependent solid tumours — molecular diagnosis and targeted therapy

    著者: , , , , , - Nature Reviews Clinical Oncology 2020 被引用: 320

  22. Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Attilio Orazi, Elli Papaemmanuil, Andreas Reiter, David M. Ross, Michael R. Savona, Akiko Shimamura, Radek C. Skoda, Françesc Solé, Richard M. Stone, Ayalew Tefferi, Matthew J. Walter, David Wu, Benjamin L. Ebert, Mario Cazzola - Blood 2022 被引用: 208

  23. The Genomic Landscape of SMARCA4 Alterations and Associations with Outcomes in Patients with Lung Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2020 被引用: 283

  24. Accelerating Discovery of Functional Mutant Alleles in Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Neal Rosen, David B. Solit, David M. Hyman, Barry S. Taylor - Cancer Discovery 2017 被引用: 426